Semen Analysis Market Research, 2031
The global semen analysis market was valued at $955.47 million in 2021, and is projected to reach $1.49 billion by 2031, growing at a CAGR of 4.5% from 2022 to 2031. Semen analysis is the term used for the laboratory techniques and procedures that are performed to measure sperm parameters, including number, motility, morphology and viability. Semen analysis is commonly performed to assess male factor infertility. A routine semen analysis should include: physical characteristics of semen (color, odor, pH, viscosity and liquefaction), volume, concentration, morphology and sperm motility and progression. To provide a correct result it is necessary to perform at least two, preferably three, separate seminal analyses with an interval between them of seven days to three months.
Growth in incidences of male infertility, and increase in awareness regarding fertility testing in both developed and developing countries are some factors that boost the growth of the semen analysis market size. In addition, innovation and advancement in male fertility testing such as automation in sperm analysis further boost the growth of the semen analysis market size. However, lack of awareness in economically poor countries about semen analysis is a restraining factor that may hamper the semen analysis market growth. On the contrary, sales of male fertility testing kits on online platform and growth potential of emerging economies create an semen analysis market opportunity for the manufacturers to tap and capitalize on the market.
Coronavirus severe acute respiration syndrome (SARS-CoV-2) is an infectious disease caused by the novel coronavirus (COVID-19), which originated in the Wuhan district in China in the late 2019, and since has spread to 212 countries. The virus was initially referred to as “novel coronavirus 2019” (2019-nCoV) by the WHO, However, on February 11, 2020, it was given the official name of SARS-CoV-2 by the International Committee on Taxonomy of Viruses. WHO declared COVID-19 as pandemic on March 11, 2020, and by September 1, 2020, over 28.1 million people have been infected globally with over 909,000 death. COVID-19 symptoms include fever, cough, and shortness of breath.
The COVID-19 pandemic in 2020 led to slow down in availability of the products for home care settings and shut down of fertility clinics to avail fertility services such as semen analysis which affect the semen analysis Industry. The COVID-19 pandemic has affected fertility clinics, owing to shutdowns in various COVID-19 affected countries and rise in number of healthcare workers falling ill in the pandemic, which is why people were unable to come to fertility clinic and diagnostic laboratories for semen analysis and treatment. However, in 2021, authorities are granting permission to slowly starting the fertility services in various regions of the world ensuring the implication of provided guidelines. For instance, the permission to open the fertility clinics were given by Human Fertilization and Embryology Authority (HFEA) in the UK on January 5, 2021.
The Human Reproduction Societies (HRS) have issued guidelines for practice during COVID-19 pandemic that include implementation of mitigation practices and infection control protocols in fertility care units. Moreover, the country like Canada have dedicated funds to support COVID-19 research.
SEMEN ANALYSIS MARKET SEGMENTATION
The semen analysis market are segmented into product, age group, end user and region. According to product, the market is categorized into semen analyzers, centrifuges for sample preparation, semen test kits, disposables & consumables, and software. Semen analyzer segment further sub-segmented into manual semen analyzer, and automated semen analyzer. By age group, it is segregated into 34 and below 34 years, 35-40 years, and 41 and greater than 41 years. On the basis of end user, it is segmented into fertility centers, hospitals, diagnostic laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment Review
On the basis of product, it is segmented into semen analyzers, centrifuges for sample preparation, semen test kits, disposables & consumables, and software. The consumable & disposable segment dominated the global semen analysis market share in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to their limited durability as well as growth in adoption of consumables & disposable during semen analysis testing. However, semen test kits segment registered highest CAGR during forecast period, owing to increase in adoption of semen test kits for home-use due to its reliable quality and easily interpretable results.
On the basis of age group, it is divided into 34 and below 34 years, 35-40 years, and 41 and greater than 41 years. The 41 and greater than 41 years segment dominated the global market in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to increase in prevalence of infertility in age between 41 and greater than 41 years. However, 35-40years segment registered highest growth registering CAGR of 4.8% during semen analysis market forecast owing to increase in the use of semen analysis tests by men between the ages of 35 and 40 to monitor sperm count and male fertility.
On the basis of end user, it is classified into fertility centers, hospitals, diagnostic laboratories, and others that include research institutes and home care setting. The fertility centers held the largest market share in 2021 and is expected to remain dominant throughout the forecast period owing to increase in the number of the infertility rates of the population as well as increase in IVF procedure and vasectomy performed in fertility centers.
On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific is predicted to dominate the growth of the semen analysis market due to surge in infertility cases and rise in awareness regarding semen analysis testing among the population. On the other hand, Europe is anticipated to be the second largest market during the analysis period owing to presence of higher number of infertility centers, rise in investment in healthcare, and increase in awareness about the healthcare technologies among Europeans.
The key market players profiled in the report include Androfert, Arquimea (Arquimea Agrotech), Bioline Technologies, Cooper Companies Inc (Cooper Surgical), DNA Diagnostics Center, Inc., FlowLabs, Hamilton Thorne Inc., Lab IVF, Leja Products B.V, Medical Electronics Systems, Michigan center for fertility & women's health, Microptic SL, Midland Fertility, MotilityCount ApS, NW Cryobank, Sperm processor, and Synergy medical systems.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the semen analysis market analysis from 2021 to 2031 to identify the prevailing semen analysis market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the semen analysis market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global semen analysis market trends, key players, market segments, application areas, and market growth strategies.
Semen Analysis Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Age Group |
|
 By End User |
|
 By Region |
|
 Key Market Players | NW Cryobank, Midland Fertility, Hamilton Thorne Inc., Cooper Companies Inc (Cooper Surgical), Medical electronics systems, Leja Products B.V, Synergy medical systems, Michigan center for fertility & women's health, Sperm processor, Arquimea (Arquimea Agrotech), Microptic SL, Androfert, FlowLabs, DNA Diagnostics Center, Inc., MotilityCount ApS, Bioline Technologies, Lab IVF |
Analyst Review
The semen analysis market is expected to witness a healthy growth with the adoption of semen analysis tests among the infertile male has increased in recent years, due to technological advancements in fertility procedures. In addition, occurrence of infertility in developing countries is expected to increase in the coming years, owing to increase in sperm-related issues in males due to lifestyle habits such as smoking & drinking and other age-related chronic diseases among the population. Furthermore, supportive government laws and legislation further supplement the demand for semen analysis tests among several communities across the globe.
The use of semen analysis test is highest in Asia-Pacific, owing to the factors such as high prevalence of infertility and growth in awareness regarding fertility testing among population and availability of technologically advanced products. Although the use of fertility test in LAMEA is low, the adoption rate is expected to increase, owing to rise in launch of new and advanced products with greater efficiency.
The total market value of semen analysis market is $955.47 million in 2021.
Disposable & consumables segment is the most influencing segment owing to increase in adoption of consumable & disposable during semen analysis testing.
Upsurge in the incidences of infertility among males within the population globally, innovation and advancement in male fertility testing and rise in awareness regarding male fertility testing are some factors expected to boost the market growth during the forecast period.
The base year is 2021 in semen analysis market
Top companies such as Androfert, Arquimea (Arquimea Agrotech), Bioline Technologies, Cooper Companies Inc (Cooper Surgical), DNA Diagnostics Center, Inc., FlowLabs, Hamilton Thorne Inc., Lab IVF, Leja Products B.V, Medical Electronics Systems held a high market position in 2021.
The forecast period for semen analysis market is 2022 to 2031
The market value of semen analysis market in 2031 is $1,486.78 million.
Loading Table Of Content...
